InspireMD Q4 EPS $(0.16) Beats $(0.20) Estimate, Sales $1.76M Beat $1.63M Estimate
InspireMD Q4 EPS $(0.16) Beats $(0.20) Estimate, Sales $1.76M Beat $1.63M Estimate
InspireMD第四季度每股收益美元（0.16美元）超過預期（0.20美元），銷售額176萬美元超過163萬美元的預期
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by 20 percent. This is a 73.33 percent increase over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $1.76 million which beat the analyst consensus estimate of $1.63 million by 8.04 percent. This is a 71.64 percent increase over sales of $1.03 million the same period last year.
InspireMD（納斯達克股票代碼：NSPR）公佈的季度虧損爲每股0.16美元，比分析師共識估計的美元（0.20美元）高出20％。這比去年同期每股虧損0.60美元（0.60美元）增長了73.33％。該公司公佈的季度銷售額爲176萬美元，比分析師普遍預期的163萬美元高出8.04％。這比去年同期的103萬美元銷售額增長了71.64％。